Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
4
First snow to fall in Seoul on Wednesday
-
5
Man convicted after binge eating to avoid military service
-
6
S. Korea not to attend Sado mine memorial: foreign ministry
-
7
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
8
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
9
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
-
10
Nvidia CEO signals Samsung’s imminent shipment of AI chips
Hanwha Chemical said Monday it had named Paul Coleman chief executive officer for its bio business unit.
Coleman, from Ireland, has worked as the company’s chief operating officer at the unit since January 2011.
“He is the right person for the post as he has proved his capabilities and leadership as the unit’s COO, especially, in making a license contract for a drug for arthritis with the global pharmaceutical giant Merck last June,” the company said in a statement.
The chemical firm, one of Hanwha Group’s affiliates, plans to expand into the bio business by reorganizing its business portfolio and hiring more foreign executives.
By Kim Young-won
(wone0102@heraldcorp.com)
-
Articles by Korea Herald
![[More than APT] Residents, architects together design homes](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/11/24/20241124050036_0.jpg&u=)
